The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase III, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of pregabalin in the prevention and reduction of oxaliplatin-induced painful neuropathy (PreOx).
 
Daniel Ciampi de Andrade
No Relationships to Disclose
 
Manoel Jacobsen Teixeira
No Relationships to Disclose
 
Ricardo Galhardoni
No Relationships to Disclose
 
Karine A.S.L. Ferreira
Employment - Janssen-Cilag
 
Paula Braz Malieno
No Relationships to Disclose
 
Nathalia Scisci
No Relationships to Disclose
 
Rachel Pimenta Riechelmann
No Relationships to Disclose
 
William G.J. Teixeira
No Relationships to Disclose
 
Daniel Fernandes Saragiotto
No Relationships to Disclose
 
Valquiria Aparecida Silva
No Relationships to Disclose
 
Irina Raicher
No Relationships to Disclose
 
Isac de Castro
No Relationships to Disclose
 
Daniella Parravano
No Relationships to Disclose
 
Julia Tizue Fukushima
No Relationships to Disclose
 
Jean-Pascal Lefaucheur
No Relationships to Disclose
 
Didier Bouhassira
No Relationships to Disclose
 
Ricardo Silvestre e Silva Macarenco
No Relationships to Disclose
 
Evandro Sobroza de Mello
No Relationships to Disclose
 
Paulo Marcelo Hoff
Consulting or Advisory Role - AstraZeneca (I)
Research Funding - Roche/Genentech